Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Neighbourly Pharmacy Inc T.NBLY

Neighbourly Pharmacy Inc. is a Canada-based company that operates a network of community pharmacies. The Company is an owner and operator of retail pharmacies located throughout Canada under banners such as IDA/Guardian, Pharmachoice, Pharmasave and Remedy’s RX. The Company, through its subsidiaries, owns and operates a network of retail pharmacies known as Rubicon Pharmacies (Rubicon or... see more

TSX:NBLY - Post Discussion

Neighbourly Pharmacy Inc > Analyst downgrade
View:
Post by incomedreamer11 on Jul 19, 2023 1:46pm

Analyst downgrade

DJ Neighbourly Pharmacy's Staffing Shortage Could Indicate Margin Pressure -- Market Talk

Wednesday, July 19, 2023, 9:04 AM ET
 

0903 ET - Neighbourly Pharmacy's larger staff vacancies list could be the canary in the coal mine for margin pressure. According to a National Bank of Canada note by Zachary Evershed. Neighbourly's open positions count reversed course in early June, which lost ground on prior improvements. Even though the job openings include postings may not affect margin recovery, Evershed says it is "directionally indicative of reliance on relief pharmacists at levels higher than we anticipated." He has downgraded his forecast on margins to 10% from a previous 10.3% "reflecting an adjustment lower to account for increased expenses owing to staffing challenges, though still up 20 bps y/y." Evershed says this should improve next year. (adriano.marchese@wsj.com)
 	

(END) Dow Jones Newswires

July 19, 2023 09:04 ET (13:04 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
 
 
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities